scholarly journals COVID-19 mitigation strategies were associated with decreases in other respiratory virus infections

2021 ◽  
Author(s):  
Sinha Pranay ◽  
Katherine Reifler ◽  
Michael Rossi ◽  
Manish Sagar
Keyword(s):  
Respiratory Virus ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Mitigation Strategies ◽  
Virus Infections ◽  
Time Period ◽  
Viral Respiratory Infections ◽  
Respiratory Virus Infections ◽  
Viral Respiratory

Abstract Detection of diverse respiratory viruses in Boston was around 80% lower after practices were instituted to limit COVID-19 spread compared to the same time period during the previous five years. Continuing the strategies that lower COVID-19 dissemination may be useful in decreasing the incidence of other viral respiratory infections.

scholarly journals Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Eteri Regis ◽  
Sara Fontanella ◽  
Lijing Lin ◽  
Rebecca Howard ◽  
Sadia Haider ◽  
...  
Keyword(s):  
Sex Differences ◽  
Immune Responses ◽  
Birth Cohort ◽  
Respiratory Virus ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Innate Immune ◽  
Innate Immune Responses ◽  
Virus Infections ◽  
Respiratory Virus Infections

AbstractThe mechanisms explaining excess morbidity and mortality in respiratory infections among males are poorly understood. Innate immune responses are critical in protection against respiratory virus infections. We hypothesised that innate immune responses to respiratory viruses may be deficient in males. We stimulated peripheral blood mononuclear cells from 345 participants at age 16 years in a population-based birth cohort with three live respiratory viruses (rhinoviruses A16 and A1, and respiratory syncytial virus) and two viral mimics (R848 and CpG-A, to mimic responses to SARS-CoV-2) and investigated sex differences in interferon (IFN) responses. IFN-α responses to all viruses and stimuli were 1.34–2.06-fold lower in males than females (P = 0.018 −  < 0.001). IFN-β, IFN-γ and IFN-induced chemokines were also deficient in males across all stimuli/viruses. Healthcare records revealed 12.1% of males and 6.6% of females were hospitalized with respiratory infections in infancy (P = 0.017). In conclusion, impaired innate anti-viral immunity in males likely results in high male morbidity and mortality from respiratory virus infections.

scholarly journals The Disappearance of Respiratory Viruses in Children during the COVID-19 Pandemic

2021 ◽  
Vol 18 (18) ◽  
pp. 9550
Author(s):  
Anna Chiara Vittucci ◽  
Livia Piccioni ◽  
Luana Coltella ◽  
Claudia Ciarlitto ◽  
Livia Antilici ◽  
...  
Keyword(s):  
Respiratory Virus ◽  
Respiratory Infections ◽  
Virus Transmission ◽  
Tertiary Hospital ◽  
Virus Infections ◽  
Epidemic Period ◽  
Syncytial Virus ◽  
Viral Respiratory Infections ◽  
Respiratory Virus Infections ◽  
The Impact

Background: Social distancing measures are used to reduce the spreading of COVID-19. The aim of this study was to assess the impact of local restrictions on the transmission of respiratory virus infections. Methods: we retrospectively analyzed the nasopharyngeal samples of all patients (0–18 years old) admitted with respiratory symptoms in a large Italian tertiary hospital during the last three seasons from 2018 to 2021. Results: A strong reduction in all viral respiratory infections was observed in the last season (2020–2021) compared to the two previous seasons (−79.69% and −80.66%, respectively). In particular, we found that during the epidemic period 2018–2019 and 2019–2020, the total number of Respiratory Syncytial Virus (RSV) cases was, respectively 726 and 689, while in the last season a total of five cases was detected. In the first months of 2018–2019 and 2019–2020, the total flu infections were 240 and 354, respectively, while in the last season we did not detect any influenza virus. As other viruses, the presence of Rhinovirus declined, but to a lesser extent: a total of 488 cases were assessed compared to the 1030 and 1165 cases of the two previous respective epidemic seasons. Conclusions: Public health interventions and distancing (including continuous use of face masks) settled to counter the pandemic spread of COVID-19 had a macroscopic impact on all respiratory virus transmission and related diseases, with a partial exception of Rhinovirus. The absence of viruses’ circulation could result in a lack of immunity and increased susceptibility to serious infections in the next seasons.

scholarly journals Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantation

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Maria Vela ◽  
Teresa del Rosal ◽  
Antonio Pérez-Martínez ◽  
Jaime Valentín ◽  
Inmaculada Casas ◽  
...  
Keyword(s):  
Nk Cells ◽  
Haematopoietic Stem Cell Transplantation ◽  
Nk Cell ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Haematopoietic Stem Cell ◽  
Healthy Controls ◽  
Cell Numbers ◽  
Viral Respiratory Infections ◽  
Viral Respiratory

AbstractInfection is the leading cause of non-relapse-related mortality after allogeneic haematopoietic stem cell transplantation (HSCT). Altered functions of immune cells in nasal secretions may influence post HSCT susceptibility to viral respiratory infections. In this prospective study, we determined T and NK cell numbers together with NK activation status in nasopharyngeal aspirates (NPA) in HSCT recipients and healthy controls using multiparametric flow cytometry. We also determined by polymerase chain reaction (PCR) the presence of 16 respiratory viruses. Samples were collected pre-HSCT, at day 0, +10, +20 and +30 after HSCT. Peripheral blood (PB) was also analyzed to determine T and NK cell numbers. A total of 27 pediatric HSCT recipients were enrolled and 16 of them had at least one viral detection (60%). Rhinovirus was the most frequent pathogen (84% of positive NPAs). NPAs of patients contained fewer T and NK cells compared to healthy controls (p = 0.0132 and p = 0.120, respectively). Viral PCR + patients showed higher NK cell number in their NPAs. The activating receptors repertoire expressed by NK cells was also higher in NPA samples, especially NKp44 and NKp46. Our study supports NK cells relevance for the immune defense against respiratory viruses in HSCT recipients.

scholarly journals 2634. Human Metapneumovirus in a Children’s Hospital: It Should Get More Attention

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S920-S920
Author(s):  
Nellie Said ◽  
Wendi Gornick ◽  
Beth Huff ◽  
Jasjit Singh
Keyword(s):  
Disease Surveillance ◽  
Vaccine Development ◽  
Respiratory Infections ◽  
Human Metapneumovirus ◽  
Time Period ◽  
Potential Vaccine ◽  
Syncytial Virus ◽  
Viral Respiratory Infections ◽  
Hospital Acquired ◽  
Viral Respiratory

Abstract Background Viral respiratory infections are a major cause of hospitalization and intensive care unit (ICU) admission to children’s hospitals. Rates of respiratory syncytial virus (RSV) and influenza are closely tracked due to their known morbidity. We had previously observed over one season that human metapneumovirus (hMPV)-infected children have high rates of hospitalizations and ICU admissions, particularly those with chronic lung disease (CLD). We expanded our data to include an additional 5 seasons to compare rates of hospitalizations and hospital-acquired infections (HAIs) due to hMPV, RSV and influenza. Methods During the 2014–2019 winter viral seasons, hMPV, RSV and influenza infections were tracked through both PCR testing (Biofire Respiratory Panel) and DFA testing (D3 Ultra DFA Respiratory Virus Screening & ID Kit; Diagnostic Hybrids). For hMPV admissions, rates of hospitalizations, ICU admissions, HAIs and mortalities were assessed and compared with RSV and influenza admissions. Retrospective data were used to study patients infected with hMPV. Results During the winter seasons of 2014–2019, the rates of hospitalization due to hMPV were significantly higher than both RSV and influenza (Figure 1). ICU admissions and HAIs for hMPV were similar to RSV and influenza (Figures 2 and 3). There were 9 deaths over this time period; 5 due to RSV, 3 due to influenza and 1 due to hMPV. The proportion of deaths due to hMPV compared with RSV and influenza was similar (P = 0.54, 0.89, respectively). Of the 315 total admissions with hMPV, 43 (13.7%) had CLD and 13 (4.1%) were tracheostomy dependent. Among 67 hMPV ICU admissions from 2014–2019, 56 (84%) had an underlying medical diagnosis, 25 (37%) had CLD, 13 (19%) had tracheostomies, and 17 (25%) required mechanical ventilation. The average age of hMPV infected children in our ICU is 4 years 1 month. Conclusion Our large descriptive study of hMPV-infected children over 6 seasons showed higher rates of hospitalization compared with RSV and influenza, similar ICU and HAI rates, and similar rates of mortality. ICU admitted children often had associated co-morbidities, including CLD. Further studies for focused disease surveillance and potential vaccine development for high-risk children are needed. Disclosures All authors: No reported disclosures.

Viral respiratory infections during the 2009 influenza A(H1N1) outbreak in the West Midlands Region, UK

2011 ◽  
Vol 140 (9) ◽  
pp. 1551-1556 ◽  
Author(s):  
H. E. TANNER ◽  
M. D. CURRAN ◽  
E. H. BOXALL ◽  
H. OSMAN
Keyword(s):  
Influenza A ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Virus Infections ◽  
Influenza Outbreak ◽  
Influenza A H1n1 ◽  
Significant Difference ◽  
West Midlands ◽  
The Uk ◽  
Viral Respiratory Infections

SUMMARYIn spring 2009 a new strain of influenza A(H1N1) emerged and caused a worldwide pandemic. This study utilized a large collection of respiratory specimens from suspected cases of influenza A(H1N1) in the UK West Midlands during the pandemic in order to investigate which other respiratory viruses were circulating and whether they played any role in the increased hospitalization rates seen during that period. Study specimens were selected from community and hospitalized patients positive and negative for influenza A(H1N1) and tested by PCR for other respiratory viruses. A number of infections diagnosed as influenza during the summer influenza outbreak were found to be due to other virus infections (most commonly rhinovirus). No statistically significant difference was found between the rates of respiratory virus co-infection with H1N1 in patients from community or hospital locations suggesting underlying factors were likely to be more significant than viral co-infections in determining severity of influenza A(H1N1) disease.

scholarly journals Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity

2021 ◽  
Vol 65 (4) ◽  
Author(s):  
Aartjan J. W. te Velthuis ◽  
Tatiana G. Zubkova ◽  
Megan Shaw ◽  
Andrew Mehle ◽  
David Boltz ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Placebo Group ◽  
Rna Polymerase ◽  
Rna Synthesis ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Virus Shedding ◽  
Virus Rna ◽  
Viral Respiratory Infections ◽  
Viral Respiratory

ABSTRACT Infections with respiratory viruses constitute a huge burden on our health and economy. Antivirals against some respiratory viruses are available, but further options are urgently needed. Enisamium iodide (laboratory code FAV00A, trade name Amizon) is an antiviral, marketed in countries of the Commonwealth of Independent States for the treatment of viral respiratory infections, but its clinical efficacy and mode of action are not well understood. In this study, we investigated the efficacy of enisamium in patients aged between 18 and 60 years with confirmed influenza virus and other viral respiratory infections. Enisamium treatment resulted in reduced influenza virus shedding (at day 3, 71.2% in the enisamium group tested negative versus 25.0% in placebo group [P < 0.0001]), faster patient recovery (at day 14, 93.9% in the enisamium group had recovered versus 32.5% in placebo group [P < 0.0001]), and reduced disease symptoms (from 9.6 ± 0.7 to 4.6 ± 0.9 score points in enisamium group versus 9.7 ± 1.1 to 5.6 ± 1.1 score points in placebo group [P < 0.0001]) compared to those in the placebo group. Using mass spectrometry, and cell-based and cell-free viral RNA synthesis assays, we identified a hydroxylated metabolite of enisamium, VR17-04. VR17-04 is capable of inhibiting influenza virus RNA synthesis and is present in plasma of patients treated with enisamium. VR17-04 inhibits the activity of the influenza virus RNA polymerase more potently than its parent compound. Overall, these results suggest that enisamium is metabolized in humans to an inhibitor of the influenza virus RNA polymerase that reduces viral shedding and improves patient recovery in influenza patients. (This study has been registered at ClinicalTrials.gov under identifier NCT04682444.)

scholarly journals Respiratory Virus Infections in Adults with Hematologic Malignancies: A Prospective Study

2003 ◽  
Vol 36 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Rodrigo Martino ◽  
Elena Rámila ◽  
Núria Rabella ◽  
José Manuel Muñoz ◽  
Mercé Peyret ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
Tract Infection ◽  
Respiratory Tract ◽  
Respiratory Tract Infection ◽  
Respiratory Virus ◽  
Hematologic Malignancies ◽  
Respiratory Viruses ◽  
Virus Infections ◽  
Syncytial Virus ◽  
Respiratory Virus Infections

Abstract During a 2-year period, 157 consecutive episodes of respiratory virus infections that occurred in 130 patients with upper or lower respiratory tract infection were analyzed for respiratory viruses. A respiratory virus was identified in 75 episodes (48%), and several viruses were found in 13 episodes: there were a total of 56 influenza A virus infections, 14 respiratory syncytial virus infections, 8 adenovirus infections, 8 infections with parainfluenza virus types 1 or 3, and 7 enterovirus infections. On multivariate analysis, the only variable that predicted progression to pneumonia in patients with an upper respiratory tract infection was the presence of respiratory syncytial virus, whereas lymphocytopenia had a nonsignificant trend. Also, among the 38 patients who had pneumonia at any time during the episode, both respiratory syncytial virus and lymphocytopenia were commonly found. For both epidemiological and therapeutic considerations, frequent screening for respiratory viruses should be incorporated into the routine diagnostic study of patients with hematologic malignancies.

scholarly journals Toll-Like Receptor 4-Mediated Activation of p38 Mitogen-Activated Protein Kinase Is a Determinant of Respiratory Virus Entry and Tropism

2010 ◽  
Vol 84 (21) ◽  
pp. 11359-11373 ◽  
Author(s):  
David Marchant ◽  
Gurpreet K. Singhera ◽  
Soraya Utokaparch ◽  
Tillie L. Hackett ◽  
John H. Boyd ◽  
...  
Keyword(s):  
Influenza Virus ◽  
P38 Mapk ◽  
Respiratory Virus ◽  
Respiratory Viruses ◽  
Mitogen Activated Protein Kinase ◽  
Toll Like Receptor ◽  
Virus Infections ◽  
Toll Like Receptor 4 ◽  
Mitogen Activated Protein ◽  
Respiratory Virus Infections

ABSTRACT Respiratory viruses exert a heavy toll of morbidity and mortality worldwide. Despite this burden there are few specific treatments available for respiratory virus infections. Since many viruses utilize host cell enzymatic machinery such as protein kinases for replication, we determined whether pharmacological inhibition of kinases could, in principle, be used as a broad antiviral strategy for common human respiratory virus infections. A panel of green fluorescent protein (GFP)-expressing recombinant respiratory viruses, including an isolate of H1N1 influenza virus (H1N1/Weiss/43), was used to represent a broad range of virus families responsible for common respiratory infections (Adenoviridae, Paramyxoviridae, Picornaviridae, and Orthomyxoviridae). Kinase inhibitors were screened in a high-throughput assay that detected virus infection in human airway epithelial cells (1HAEo-) using a fluorescent plate reader. Inhibition of p38 mitogen-activated protein kinase (MAPK) signaling was able to significantly inhibit replication by all viruses tested. Therefore, the pathways involved in virus-mediated p38 and extracellular signal-regulated kinase (ERK) MAPK activation were investigated using bronchial epithelial cells and primary fibroblasts derived from MyD88 knockout mouse lungs. Influenza virus, which activated p38 MAPK to approximately 10-fold-greater levels than did respiratory syncytial virus (RSV) in 1HAEo- cells, was internalized about 8-fold faster and more completely than RSV. We show for the first time that p38 MAPK is a determinant of virus infection that is dependent upon MyD88 expression and Toll-like receptor 4 (TLR4) ligation. Imaging of virus-TLR4 interactions showed significant clustering of TLR4 at the site of virus-cell interaction, triggering phosphorylation of downstream targets of p38 MAPK, suggesting the need for a signaling receptor to activate virus internalization.

scholarly journals Contribution of Viral Respiratory Infections to Dengue-Like Illness Presentation at a Community Clinic in Southern Malaysia

2021 ◽  
Author(s):  
Amreeta Dhanoa ◽  
Chin Fang Ngim ◽  
Nor’azim Mohd Yunos ◽  
Syed M. Tupur Husain ◽  
Lian Yih Pong ◽  
...  
Keyword(s):  
Odds Ratio ◽  
Respiratory Infections ◽  
Respiratory Viruses ◽  
Multiple Logistic Regression ◽  
Chain Reaction ◽  
Community Clinic ◽  
History Of ◽  
Polymerase Chain ◽  
Viral Respiratory Infections ◽  
Viral Respiratory

This study explored the contribution of viral respiratory infections (VRIs) in dengue-like illness (DLI) patients and their distinguishing clinicolaboratory parameters. Two hundred DLI patients were prospectively recruited (1 July–1 October 2019) from a community clinic in Southern Malaysia. Patients ≥18 years with acute fever and fulfilling the WHO criteria of probable dengue were recruited. They underwent blood testing: blood counts, rapid dengue tests (nonstructural antigen-1/IgM) and polymerase chain reaction (PCR) for dengue, Zika, chikungunya, and Leptospira. Nasopharyngeal swabs (NPSs) were collected for FilmArray®RP2plus testing. From the 200 NPSs, 58 respiratory viruses (RVs) were detected in 54 patients. Of the 96 dengue-confirmed cases, 86 had dengue mono-infection, and 10 were coinfected with RVs. Of the 104 nondengue, 44 were RV positive and 4 Leptospira positive. Zika and chikungunya virus were not detected. Overall, the etiological diagnosis was confirmed for 72% of patients. Clinicolaboratory parameters were compared between dengue mono-infection and VRI mono-infection. Patients with coinfections were excluded. Multiple logistic regression showed that recent household/neighborhood history of dengue (adjusted odds ratio [aOR]: 5.9, 95% CI = 1.7–20.7), leukopenia (aOR: 12.5, 95% CI = 2.6–61.4) and thrombocytopenia (aOR: 5.5, 95% CI = 1.3–23.0) predicted dengue. Inversely, rhinorrhoea (aOR: 0.1, 95% CI = 0.01–0.3) and cough (aOR: 0.3, 95% CI = 0.1–0.9) favored VRI. Thus, VRIs comprise many infections diagnosed initially as DLIs. Early clinicolaboratory parameters can guide physicians screen patients for further testing.

Reduction in Rate of Nosocomial Respiratory Virus Infections in a Children’s Hospital Associated With Enhanced Isolation Precautions

2018 ◽  
Vol 39 (2) ◽  
pp. 152-156 ◽  
Author(s):  
Lorry G. Rubin ◽  
Nina Kohn ◽  
Susan Nullet ◽  
Margaret Hill
Keyword(s):  
Respiratory Virus ◽  
Viral Infections ◽  
Respiratory Infections ◽  
Medical Center ◽  
Tertiary Care ◽  
Virus Infections ◽  
Children's Hospital ◽  
Children’S Hospital ◽  
Respiratory Virus Infections ◽  
Hospital Days

OBJECTIVETo determine whether the use of enhanced isolation precautions (droplet and contact precautions) for inpatients with respiratory tract viral infections is associated with a reduction in rate of nosocomial viral respiratory infections.DESIGNQuasi-experimental study with the rate of nosocomial respiratory virus infection as the primary dependent variable and rate of nosocomialClostridium difficileinfection as a nonequivalent dependent variable comparator.SETTINGCohen Children’s Medical Center of NY, a tertiary-care children’s hospital attached to a large general hospital.INTERVENTIONDuring years 1 and 2 (July 2012 through June 2014), the Centers for Disease Control and Prevention/Healthcare Infection Control Practices Advisory Committee’s recommended isolation precautions for inpatients with selected respiratory virus infections were in effect. Enhanced isolation precautions were in effect during years 3 and 4 (July, 2014 through June, 2016), except for influenza, for which enhanced precautions were in effect during year 4 only.RESULTSDuring the period of enhanced isolation precautions, the rate of nosocomial respiratory virus infections with any of 4 virus categories decreased 39% from 0.827 per 1,000 hospital days prior to enhanced precautions to 0.508 per 1,000 hospital days (P<.0013). Excluding rhinovirus/enterovirus infections, the rates decreased 58% from 0.317 per 1,000 hospital days to 0.134 per 1,000 hospital days during enhanced precautions (P<.0014). During these periods, no significant change was detected in the rate of nosocomialC. difficileinfection.CONCLUSIONSEnhanced isolation precautions for inpatients with respiratory virus infections were associated with a reduction in the rate of nosocomial respiratory virus infections.Infect Control Hosp Epidemiol2018;39:152–156

Sign in / Sign up

Export Citation Format

Share Document